In today’s post:
Trump Wants 4x More Weapons! 💣
The $3 Drug Bombshell 🤯
The Oil Panic Is a Trap ⚠️

Become An AI Expert In Just 5 Minutes
If you’re a decision maker at your company, you need to be on the bleeding edge of, well, everything. But before you go signing up for seminars, conferences, lunch ‘n learns, and all that jazz, just know there’s a far better (and simpler) way: Subscribing to The Deep View.
This daily newsletter condenses everything you need to know about the latest and greatest AI developments into a 5-minute read. Squeeze it into your morning coffee break and before you know it, you’ll be an expert too.
Subscribe right here. It’s totally free, wildly informative, and trusted by 600,000+ readers at Google, Meta, Microsoft, and beyond.

TRUMP WANTS 4X MORE WEAPONS 💣
The U.S. defense industry just got a very loud wake-up call from Washington.
Donald Trump announced that several of America’s biggest defense contractors have agreed to quadruple production of what he called “exquisite class weaponry.”
Translation: the Pentagon wants a lot more missiles… and fast.
And the companies involved aren’t exactly small startups.
We’re talking about the heavyweights of the military-industrial complex:
BAE Systems $BAER ( ▼ 5.77% )
Lockheed Martin $LMT ( ▲ 2.56% )
Boeing $BA ( ▲ 4.08% )
RTX $RTX ( ▲ 2.89% )
Northrop Grumman $NOC ( ▲ 2.18% )
Honeywell $HON ( ▼ 1.3% )
L3Harris Technologies $LHX ( ▲ 2.16% )
Basically the Avengers of the defense sector.
Why Now?
Because modern warfare burns through munitions like a teenager burns through Wi-Fi data.
The U.S. has been using large amounts of missiles and interceptors in ongoing operations — including recent strikes involving Iran and Venezuela, according to Trump.

At the same time, America is juggling multiple geopolitical chessboards:
The Middle East
Ukraine
The Indo-Pacific
Each one requires very expensive, very sophisticated weapons.
And those things take years to build.
So Washington’s solution?
Build more. A lot more.
What “Exquisite Class” Actually Means
“Exquisite” in Pentagon-speak basically means high-end, precision weapons.
Think:
Patriot interceptors
THAAD missile defenses
Tomahawk cruise missiles
Advanced air-to-air missiles

These aren’t cheap fireworks.
Some interceptors cost millions of dollars each.
And stockpiles have been under pressure as global conflicts ramp up.
The Defense Spending Flywheel
Here’s the key investing takeaway:
Defense spending is becoming structural, not cyclical.
For decades, defense budgets rose and fell with wars.
Now?
Governments are treating military capacity like infrastructure.

That means:
Long-term procurement contracts
Multi-year production agreements
Factory expansions
Supply chain investment
And the companies benefiting from that pipeline are exactly the ones sitting in that White House meeting.
The Quiet Bull Case for Defense Stocks
If production really quadruples, it means three things:
Massive order backlogs
Higher factory utilization
Longer revenue visibility
In other words:
Wall Street’s favourite thing.
Predictable cash flow.

Defense companies already operate on multi-year contracts, but a production surge like this can stretch those pipelines a decade or more.
The Big Picture
When the world gets more chaotic…
Defense contractors get busier.
And if geopolitical tensions stay elevated — which, let’s be honest, they probably will — the global arms race could quietly become one of the largest industrial expansions of the decade.
Not exactly bullish for world peace.
But for defense stocks?
Different story.
TL;DR
Trump says major U.S. defense contractors will quadruple production of “exquisite class weaponry.”
Companies involved include Lockheed Martin, RTX, Boeing, Northrop Grumman, BAE Systems, Honeywell, and L3Harris.
The move comes as global conflicts increase demand for advanced missiles and interceptors.
Modern warfare burns through munitions quickly — forcing governments to scale production fast.
For investors, the shift signals long-term demand growth for defense contractors.

1. Ride the Defense Spending Boom
Quadrupling production of “exquisite class weaponry” means the U.S. defense industry is about to enter a multi-year manufacturing cycle. When governments expand weapons production, contracts tend to last years, not months, creating massive order backlogs and predictable cash flows for defense companies.
📌 Action: Build exposure to major defense contractors like $LMT ( ▲ 2.56% ), $NOC ( ▲ 2.18% ), $RTX ( ▲ 2.89% ), or $BAESY ( ▲ 2.9% ). These companies typically benefit the most from large Pentagon procurement cycles and long-term missile production programs.
2. Invest in the Missile Supply Chain
When production quadruples, it’s not just the prime contractors that benefit. Missile systems require engines, guidance chips, sensors, radar components, and materials. This creates demand across the broader defense supply chain.
📌 Action: Add exposure to suppliers like $LHX ( ▲ 2.16% ) (communications & targeting systems) or $HON ( ▼ 1.3% ) (aerospace components and avionics). These companies often see revenue rise as contractors ramp production across multiple weapons platforms.
3. Buy the Geopolitical Hedge
Defense stocks historically perform well during periods of rising geopolitical tension, acting almost like a hedge when global instability increases. If tensions with Iran, China, or other regions remain elevated, governments will continue increasing military spending.
📌 Action: Hold a diversified defense ETF like $ITA or $PPA to capture the entire defense sector rather than betting on a single company. This spreads exposure across missiles, aircraft, cybersecurity, and defense electronics. CHAOS CAN BE A PORTFOLIO HEDGE 🌍

Daily Bull Run Premium+ 🐂
Here’s the link to today’s Daily Bull Run Premium+ stock analysis if you haven’t seen it in your inbox already today!
We covered a stock that is setting up to be part of a huge AI gold rush…. and things are just getting started!

THE $3 DRUG BOMBSHELL 🤯
Here’s a number that might make pharma executives spill their coffee.
A monthly supply of generic semaglutide — the active ingredient in Ozempic and Wegovy — could cost less than $3 per person.
Yep. Three dollars.
That’s according to a new study analyzing 2024–2025 shipment records for semaglutide and estimating manufacturing costs, taxes, packaging, and profits.
And the results are… spicy.
The Actual Cost of the Drug
Researchers estimate the true manufacturing cost of semaglutide looks something like this:
Injectable generic semaglutide:
$28–$140 per person per yearOral semaglutide:
$186–$380 per year

Right now, the branded versions — Ozempic and Wegovy — cost hundreds of dollars per month in many markets.
Even after Novo Nordisk’s $NVO ( ▼ 1.25% ) recent price cuts, the drugs will still cost about $675 per month starting next year.
So the potential generic price?
Less than the cost of a gym membership.
Why This Matters for Novo Nordisk
The study arrives at a pretty awkward moment for Novo Nordisk.
The Danish pharma giant has been riding the GLP-1 wave like a surfer who caught the perfect tsunami.
Ozempic and Wegovy turned the company into one of the most valuable healthcare firms on the planet.
But here’s the catch: Patents don’t last forever.

Novo already warned investors that profits could fall up to 13% in 2026, partly because semaglutide patents will begin expiring in some markets.
When that happens…
Generics enter the chat.
And They’re Coming Fast
Generic versions are expected to launch as early as 2026 in several countries including:
India
China
Canada
Brazil
Turkey
That matters because demand for GLP-1 drugs is exploding globally.

Researchers estimate generic semaglutide could be made available across 160 countries, where:
69% of people live with Type 2 diabetes risk factors
84% face obesity prevalence issues
In other words:
This drug isn’t just a blockbuster. It’s a global megatrend.
The Big Question for Investors
If generics can produce semaglutide for $28–$140 per year, the obvious question becomes:
How long can branded drugs maintain their massive pricing power?
Pharma companies usually defend their profits with:
patents
manufacturing complexity
regulatory barriers
brand trust
But once generics arrive… Prices tend to fall fast.
And investors know it.
What This Means for the GLP-1 Market
Even if prices drop dramatically, the overall market might still explode.
Why?
Because lower prices unlock mass adoption.
Think about it like smartphones:
First they were luxury tech.
Then prices fell.
Now everyone has one.

Weight-loss drugs could follow the same path.
Which means:
The GLP-1 market might shift from high-margin niche drug…
to mass-market global therapy.
TL;DR
A new study suggests generic semaglutide could cost under $3 per month to produce.
Injectable versions may cost $28–$140 per year to manufacture.
Novo Nordisk recently cut prices, but Wegovy/Ozempic will still cost about $675/month next year.
Generic competition may begin in 2026 as patents expire in some countries.
Generics are expected across India, China, Canada, Brazil, Turkey, and potentially 160 countries total.
Novo Nordisk already warned profits could fall up to 13% in 2026.
Lower prices could dramatically expand the global GLP-1 market.

THE OIL PANIC IS A TRAP ⚠️
Oil prices just did the financial equivalent of chugging a triple espresso.
The trigger? Tensions involving Iran sent crude markets into panic-buy mode, pushing prices higher in a hurry.
But according to David Rosenberg, founder of Rosenberg Research, investors should probably relax a little.
Because historically…
Oil spikes caused by geopolitics tend to burn out fast.
History Says: “We’ve Seen This Movie”
Rosenberg points to a couple of moments when oil markets completely lost their minds:
• During the Russian invasion of Ukraine, crude surged to about $120 per barrel.
• During the Gulf War, oil prices literally doubled overnight.
At the time, both felt like the start of a new energy crisis.
Today?
Most investors barely remember them.
Markets eventually stabilized. Oil cooled off. Life went on.
Rosenberg’s takeaway: “This too shall pass.”
Why Oil Spikes Usually Self-Destruct
Here’s the weird thing about oil shocks:
High prices kill their own rally.
When oil shoots higher, it squeezes consumers and businesses.
Gas gets expensive. Shipping gets expensive. Everything gets expensive.
And when that happens…
People start using less oil.
Economists call this demand destruction.
When energy gets pricey enough, the economy taps the brakes — and oil demand drops.
That drop in demand eventually drags prices back down.
Short-Term Pain Is Still Real
None of this means the spike doesn’t hurt.
Right now?
Gas stations are becoming the place where wallets go to cry.
Rosenberg says we’re in “nail-biting time” for traders and consumers.
The only small cushion might come from tax refunds hitting consumers’ bank accounts.
But don’t expect a spending boom.
Most of that money will probably go toward rent, groceries, and fuel, not beach holidays or luxury splurges.
The Economy Is Built Differently Now
One reason oil shocks don’t hit as hard as they used to:
The global economy doesn’t run on oil the way it did in the 70s or 80s.
We’ve shifted toward a service-heavy economy with lower energy intensity.
Less steel mills. More software subscriptions.
That makes the system more shock-resistant when energy prices spike.
Still…
If you’re a trucker, airline, or commuter filling a massive pickup truck every week, the pain is very real.
The Likely Timeline
Rosenberg’s base case is simple:
If the Iran-related tensions drag on for weeks — not months…
Markets will likely digest the shock within 3–4 months.
Because oil prices historically move like a sine wave:
Spike.
Cool off.
Spike again.
Repeat.
In other words…
Oil doesn’t usually stay in panic mode forever.
TL;DR
• Iran tensions pushed oil prices higher fast
• Economist David Rosenberg says geopolitical oil spikes rarely last
• Similar spikes happened during the Ukraine war and Gulf War
• High oil prices trigger demand destruction, which eventually pulls prices down
• Consumers will feel short-term pain at the pump
• The modern economy is less oil-dependent than decades ago
• If the conflict stays contained, markets could normalize in 3–4 months




